Latest News about ABBV
Recent news which mentions ABBV
Mastering Market Trends: The 7 Best Blue-Chip Stocks for Today’s Economy
November 29, 2023
From InvestorPlace
AbbVie's Lung Cancer Study Shows Encouraging Clinical Benefits In Subtype Of Patients
November 29, 2023
Tickers
ABBV
From Benzinga
Medtronic Stock: Bull vs. Bear
November 29, 2023
From Motley Fool
3 Rising Stars: Invest Now in Tomorrow’s Trillion-Dollar Companies
November 26, 2023
From InvestorPlace
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
November 26, 2023
From Motley Fool
3 "Boring" Stocks That Could Make You Rich
November 21, 2023
From Motley Fool
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
November 21, 2023
From Motley Fool
Dual Powerhouses: 7 Dividend Stocks Marrying High Yield With High Growth
November 20, 2023
From InvestorPlace
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
November 20, 2023
Tickers
ABBV
From Benzinga
7 High-Yield Blue Chips Suitable for Any Retiree
November 17, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
From Benzinga
Curis’s stock rises as analysts see ‘the next Pharmacyclics’
November 17, 2023
From MarketWatch
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
From Benzinga
AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?
November 16, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
From Benzinga
7 Dividend Stocks Every Investor Should Own to Survive a Market Crash
November 14, 2023
From InvestorPlace
2 High-Yield Dividend Stocks You Can Buy Now and Hold for a Decade
November 14, 2023
From Motley Fool
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing
November 14, 2023
From Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
From Benzinga
AbbVie's $21 Billion Drug Humira Is on the Decline. Should You Still Buy This Dividend Stock?
November 10, 2023
Tickers
ABBV
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.